
|Articles|August 1, 2006
- Pharmaceutical Executive-08-01-2006
- Volume 0
- Issue 0
Getting Better
Is the golden age of drug development over? Fat chance. Decade-by-decade comparisons show how new medicines improve on old ones. And that's innovation.
Advertisement
Articles in this issue
almost 20 years ago
Time Machinealmost 20 years ago
States Curb Marketingalmost 20 years ago
From the Editor: Take Your Seatalmost 20 years ago
Viewpoint: In Your Wordsalmost 20 years ago
Quiz Answersalmost 20 years ago
Introduction: Pharm Exec at 25almost 20 years ago
How Far We've ComeAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5




